The European Wound Management Association (EWMA) 2020 Level Seven curriculum recommends the provision of training on sharp debridement, primarily targeting specialist practitioners in wound care. Given the current lack of regulation for wound specialists in the UK, the quality and fidelity of training play a crucial role in health professionals' confidence when performing sharp debridement. Consequently, it is vital that training aids and methods accurately represent the realities of this procedure. Existing literature outlines training approaches using animal tissue or grapefruit models for sharp debridement. The University of Salford has developed a new simulation aid to teach tissue viability students about sharp debridement. This article details the development process and the creation of this innovative training aid designed to support sharp debridement education. The proposed simulation aid enables accurate representation of various wound tissue types requiring debridement in clinical settings, while eliminating the production of organic waste and the need for animal products, which may be objectionable to some learners.

KEY WORDS：Necrosis Sharp debridement Simulation Slough Wound

MATTHEW WYNN Lecturer in Adult Nursing, University of Salford

Correspondence: Room 3.42 Mary Seacole Building, University of Salford, Salford

 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。 DANIELLE MAYO Clinical skills technician, University of Salford

      Non-healing wounds are common, have a negative impact on patients, increase workload for clinicians and are a source of rising costs for the NHS. Early identification of people who are at risk of non-healing is important to ensure best practice interventions including the use of active treatments. This article will discuss best practice recommendations from the new Wounds UK Best Practice Statement (BPS; Wounds UK, 2022) with a focus on patient assessment and identification of risk factors for non-healing wounds, as well as examples of early intervention with active treatments to improve patient outcomes.

KEY WORDS

Best Practice Statement Non-healing wounds Patient assessment Risk factors

DR CAROLINE DOWSETT Clinical Nurse Specialist Tissue Viability, East London NHS Foundation Trust and Independent Nurse Consultant Wound Care.

This article and the best practice statement were sponsored by Smith+Nephew. The views presented in this document are the work of the author and do not necessarily reflect the views of Smith+Nephew.

EXPERT WORKING GROUP:

■ Jacqui Fletcher, Independent Nurse Consultant and Clinical Editor of Wounds UK

■ Melissa Rochon, Trust Lead for SSI Surveillance, Research and Innovation, Directorate of Infection, Guy’s and St Thomas’ NHS Foundation Trust

■ Joshua Totty, Clinical Lecturer in Plastic Surgery, University of Hull

■ Jennie Wilson, Professor of Healthcare Epidemiology, College of Nursing, Midwifery and Healthcare, University of West London

■ Lucy Woodhouse, Clinical Lower Limb Tissue Viability Lead, Wye Valley NHS Trust

■ Kylie Sandy-Hodgetts, Associate Professor, Centre for Molecular Medicine & Innovative Therapeutics; Director, Skin Integrity Institute, Murdoch University; Adjunct Senior Research Fellow, School of Biomedical Sciences, University of Western Australia

REVIEWERS:

■ Mel Burden, Consultant Nurse & Joint Director, Infection Prevention and Control, Tissue Viability, Royal Devon and Exeter Hospital

■ Lisa Butcher, Lead Nurse for Infection Prevention & Control, Oxford University Hospitals NHS Foundation Trust; President of Infection Prevention Society

■ Lilian Chiwera, Independent Surgical Site Infection Surveillance & Prevention Consultant, IPC/SSI Prevention Matron, Sherwood Forest NHS Trust

■ Rhidian Morgan-Jones, Consultant Revision Knee Surgeon, Schoen Clinic, London

■ Judith Tanner, Professor of Adult Nursing, Faculty of Medicine & Health Sciences, University of Nottingham

BEST PRACTICE STATEMENT: SSI SURVEILLANCE: PROMOTING A SEAMLESS PATIENT JOURNEY FROM SURGERY TO COMMUNITY

PUBLISHED BY:

Wounds International A division of Omniamed, 108 Cannon Street, London EC4N 6EU, UK

Tel: +44 (0)20 3735 8244

Web: www.woundsinternational.com

© Wounds International, 2023

This document has been developed by Wounds International and is supported by an unrestricted educational grant from Essity.

This publication was coordinated by Wounds International with the Expert Working Group. The views presented in this document are the work of the authors and do not necessarily reflect the views of Essity.

Suggested citation:

Wounds International (2023) SSI Surveillance: Promoting a seamless patient journey from surgery to community. Wounds International, London

Available to download from: www.woundsinternational.com

EXPERT PANEL

Luxmi Dhoonmoon (Co-chair), Tissue Viability Nurse Consultant, Central and North West London NHS Foundation Trust

Harikrishna K.R. Nair (Co-chair), Head and Consultant of Wound Care Unit, Department of Internal Medicine, Kuala Lumpur Hospital, Malaysia; Professor, Faculty of Medicine, Lincoln University Malaysia; Professor, Institute of Health Management; Austria, Adjunct Professor, Department of Surgery, Institute of Medical Sciences, Banares Hindu University, India; Executive Director, College of Wound Care Specialists

Zulfiqarali Abbas, Endocrinologist, Department of Internal Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam; Abbas Medical Centre, Dar es Salaam, Tanzania

Ethel Andrews, Wound Specialist, Life Brenthurst Hospital/Netcare Mulbarton Hospital, Johannesburg, South Africa; Visiting Lecturer, University of Witwatersrand; Past President, South African Burn Society; International Burns Society Nurse Award recipient 2022

Simone McConnie, Diabetic Footcare Specialist Podiatrist, Comfeet Foot Care Clinic, Barbados

Jennifer Pearson, Head of Nursing Royal Orthopaedic Hospital Birmingham; BAME Nurse of the Year 2022; Regional Lead Chief Nursing Officer (England), Black Minority Ethnic Strategic Advisory Group

Mohamed Waheed, Plastic Surgeon, Head of the Department of Surgery, Indira Gandhi Memorial Hospital, Maldives

Mandika Wijeyaratne, Head of the Department of Surgery, Faculty of Medicine, University of Colombo, Sri Lanka

PUBLISHED BY:

Wounds International 108 Cannon Street London EC4N 6EU, UK

Tel: + 44 (0)20 7627 1510 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。 www.woundsinternational.com © Wounds International, 2023

FOREWORD

      While patient populations vary across the world, evidence shows that in many areas there are discrepancies in wound care due to variations in skin tone; for example, patients with dark skin are more likely to be diagnosed with higher-category pressure ulcers (PUs) (Oozageer Gunowa et al, 2017). This is due to a lack of accurate assessment and early identification; for example, the initial "redness" seen on light skin may not be present in dark skin and thus be missed in the initial assessment. The majority of existing evidence around skin tones in wound care is in the field of PUs, with a lack of evidence identified in other conditions and wound types (Oozageer Gunowa, 2022).

      A literature search published in 2022 (Oozageer Gunowa, 2022) highlighted gaps in the evidence around skin tones and the need for further research in this area of patient care. Further, in wound care education, there is a need for the inclusion of dark skin tones in casestudies and photographs as well as to address the gap in bias around light skin tones and lack of understanding of how to assess different skin tones (Dhoonmoon et al, 2021).

      Skin changes in people with dark skin tones are not observed quickly enough on a global scale. ‘Global Majority’ is a collective term for people who are Black, Asian, Brown, dual-heritage, indigenous to the global south, and or have been racialised as 'ethnic minorities'; globally, these groups currently represent approximately 80% of the world's population (Campbell-Stephens, 2020).

      To address these gaps, a group of global experts convened for an online meeting in September 2022 to develop this international consensus document, focusing on inclusive language, assessment, and treatment of all skin tones, to improve patient outcomes. The members of the expert group work in different areas of the world, with differing patient groups and within different healthcare systems; the aim of this meeting and the resulting document was to learn from shared experiences and provide guidance on best practice to improve outcomes for all patients, with a differing range of skin tones.

      This international consensus document aims to:

▆ Provide practical guidance on accurate assessment and diagnosis in all skin tones

▆ Provide guidance on language and descriptors to use, aiding clear patient communication

▆ Discuss different geographical and cultural considerations across the globe

▆ Dispel myths relating to skin tones

▆ Focus on the future, the need for education and how outcomes can continue to improve.

      The overall aim is to improve clinician confidence in delivering best practice to all patients, with the ultimate aim of improving patient experiences and outcomes.

Luxmi Dhoonmoon (Co-chair)

Harikrishna K. R. Nair (Co-chair)

Patient assessment is the foundation of all care. Effective treatment cannot be commenced without

accurate and thorough patient-centred assessment. Assessment may also mean that key preventative

measures can be put in place that reduce a patient’s risk of requiring further care.

A thorough inspection of the skin should be performed, as well as a baseline knowledge of identifying

and taking into account the patient's baseline skin tone so that any changes to the patient's skin

can be monitored and identified early (Dhoonmoon et al, 2021). A lack of early identification of skin

changes can mean that important signs are missed, which can lead to further and preventable skin

and tissue breakdown and damage.

A holistic wound assessment considers the entire patient, including their health, environment,

physical, psychological and psychosocial factors, as well as their skin tone. Although not well

documented, different skin tones respond differently to injury, pressure, healing and treatment.

Therefore, it is critical that the assessment and any subsequent care are tailored to the individual

patient and their needs from the beginning.

A holistic assessment should include:

▆ The patient’s skin including their skin tone

▆ Their overall health

▆ Their medical history

▆ Their wound or skin condition

▆ Their lifestyle and environment

▆ Their individual needs and preferences

▆ Their education and ability to follow information and guidance, especially when caring for a wound at home

▆ Their socioeconomic status, as treating skin conditions in a private hospital setting can be expensive, and treatments may take longer to work depending on skin type and vascular status.